EN
登录

GE医疗两套心脏成像和评估系统获CE标志

GE HealthCare Receives CE Marks for Two Cardiac Imaging and Assessment Systems

mpo-mag 等信源发布 2024-08-26 13:14

可切换为仅中文


GE HealthCare has received CE marks for its Vscan Air SL wireless handheld ultrasound system with Caption AI, an artificial intelligence (AI)-driven software for rapid cardiac assessments at the point of care, and the ECG-less Cardiac computed tomography (CT) scanning on its Revolution Apex platform, which allows clinicians access to cardiac images without the aid of the patient’s electrocardiogram (ECG) signal/trace. .

GE HealthCare已获得Vscan Air SL无线手持超声波系统的CE标志,该系统带有Caption AI,这是一种人工智能(AI)驱动的软件,用于在护理点进行快速心脏评估,以及在其Revolution Apex平台上进行的无ECG心脏计算机断层扫描(CT),该平台允许临床医生在不借助患者心电图(ECG)信号/轨迹的情况下访问心脏图像。。

“With diseases of the heart and blood vessels representing nearly one-third of all global deaths, innovation within cardiac diagnostics and treatment is one of our top priorities as a healthcare company,” said Phil Rackliffe, president and CEO of Ultrasound and Image Guided Therapies, GE HealthCare.

GE healthcare超声波和图像引导疗法总裁兼首席执行官Phil Rackliffe表示:“由于心脏和血管疾病占全球死亡人数的近三分之一,因此心脏诊断和治疗领域的创新是我们作为医疗保健公司的重中之重。”。

“The integration of Caption AI on Vscan Air SL is a major step toward helping more users confidently capture diagnostic-quality images to inform clinical decisions when time is of the essence. With the recent CE mark, we’re eager to bring this technology to more healthcare providers around the world.”.

“在Vscan Air SL上集成Caption AI是朝着帮助更多用户自信地捕获诊断质量图像以告知临床决策(时间至关重要)迈出的重要一步。凭借最近的CE标志,我们渴望将这项技术带给世界各地更多的医疗保健提供商。”。

The Vscan Air SL with Caption AI is ultraportable and is designed to help more healthcare professionals capture cardiac images and will be able to make better-informed diagnoses and treatment plans. Access to this novel technology enables earlier heart disease detection and expands cardiac care into primary care and emergency settings. .

带字幕AI的Vscan Air SL超便携,旨在帮助更多医疗保健专业人员捕捉心脏图像,并能够做出更好的诊断和治疗计划。使用这种新技术可以早期发现心脏病,并将心脏护理扩展到初级保健和急诊环境。。

Vscan Air SL with Caption AI can provide real-time, step-by-step visual guidance to optimize probe movements and includes a quality meter to ensure the user obtains the best possible images. Once a user captures an image, the AutoEF (ejection fraction) feature automatically calculates a left ventricular ejection fraction (LVEF), an important measure of heart function..

带有字幕AI的Vscan Air SL可以提供实时、逐步的视觉指导,以优化探头运动,并包括一个质量计,以确保用户获得尽可能最佳的图像。一旦用户捕获图像,AutoEF(射血分数)功能会自动计算左心室射血分数(LVEF),这是衡量心脏功能的重要指标。。

ECG-less Cardiac CT solution is already FDA-cleared and can acquire cardiac images without the aid of the patients’ ECG signal/trace. This technology is applied in examinations where it is clinically advantageous to prioritize patient access or speed when the ECG signal is unavailable.

无ECG心脏CT解决方案已获得FDA批准,可以在无需患者ECG信号/迹线的帮助下获取心脏图像。该技术应用于临床上有利的检查中,当ECG信号不可用时,优先考虑患者访问或速度。

ECG-less Cardiac CT scanning further enhances the capabilities of the company’s Revolution Apex Elite, which already boasts a 160mm detector configuration and the ability to achieve one-beat, high-definition, motion-free coronary images at any heart rate. This system is available as a part of GE HealthCare’s broader Revolution Apex platform..

无心电图心脏CT扫描进一步增强了该公司Revolution Apex Elite的功能,该公司已经拥有160mm的探测器配置,并能够在任何心率下实现单次搏动,高清,无运动的冠状动脉图像。该系统是GE HealthCare更广泛的Revolution Apex平台的一部分。。

“Providing rapid, flexible and at the point of care cardiac diagnostics is critical in terms of patient outcomes – however, timely care can be extremely difficult to deliver, particularly within already-stretched healthcare systems where clinicians face time and resource constraints,” said Eigil Samset, general manager, Cardiology Solutions, GE HealthCare.

GE healthcare心脏病学解决方案总经理Eigil Samset说:“提供快速、灵活和即时的心脏诊断对于患者预后至关重要,然而,及时护理可能极为困难,特别是在已经捉襟见肘的医疗保健系统中,临床医生面临时间和资源限制。”。

“Through our innovative cardiology solutions and by leveraging the power of AI, we aim to address these challenges and help clinicians understand the complete story of their patients’ hearts as quickly as possible. I am thrilled that this suite of integrated cardiac care solutions is now accessible to more providers so that they are able to deliver efficient and timely patient care when and where it is needed most.”.

“通过我们创新的心脏病学解决方案和利用人工智能的力量,我们的目标是应对这些挑战,并帮助临床医生尽快了解患者心脏的完整故事。我很高兴这套集成的心脏护理解决方案现在可供更多的提供者使用,以便他们能够在最需要的时候和地点提供高效及时的患者护理。”。

Both technologies will be showcased at the European Society of Cardiology (ESC) Congress, in London, August 30-September 2, 2024.

这两项技术将在2024年8月30日至9月2日于伦敦举行的欧洲心脏病学会(ESC)大会上展示。